EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H18BrClN2O |
| Net Charge | 0 |
| Average Mass | 393.712 |
| Monoisotopic Mass | 392.02910 |
| SMILES | COCC1CN=C(c2ccccc2Cl)c2cc(Br)ccc2N1C |
| InChI | InChI=1S/C18H18BrClN2O/c1-22-13(11-23-2)10-21-18(14-5-3-4-6-16(14)20)15-9-12(19)7-8-17(15)22/h3-9,13H,10-11H2,1-2H3 |
| InChIKey | WABYCCJHARSRBH-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| metaclazepam (CHEBI:135621) is a benzodiazepine (CHEBI:22720) |
| Synonyms | Source |
|---|---|
| brometazepam | DrugCentral |
| Ka 2527 | DrugCentral |
| metaclazepam hydrochloride | DrugCentral |
| metuclazepam | DrugCentral |
| metaclazepam HCl | DrugCentral |
| Ka-2527 | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| 1716 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:84031-17-4 | DrugCentral |